Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ferrer

Showing results (701-710 of 950) with videos related to

Pageof 95
Sort By:
Scientific Reports|March 11, 2020
NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortiumJose Manuel Sánchez-Maldonado, Manuel Martínez-Bueno, Helena Canhão, et al.
Frontiers in Immunology|November 15, 2021
Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large CohortsJose Manuel Sánchez-Maldonado, Rafael Cáliz, Miguel Ángel López-Nevot, et al.
The Pharmacogenomics Journal|October 6, 2018
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patientsLuz M Canet, Jose M Sánchez-Maldonado, Rafael Cáliz, et al.
The Pharmacogenomics Journal|February 15, 2019
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patientsLuz M Canet, Jose M Sánchez-Maldonado, Rafael Cáliz, et al.
Acta Otorrinolaringologica Espanola|June 12, 2026
Comprehensive Cancer Centre Accreditation: Experience and Achievements of a Head Neck Cancer UnitF X Avilés-Jurado, I Valduvieco, S Medrano-Martorell, et al.
Global Heart|March 17, 2025
Characterization of 2,500 Patients with Heart Failure and Analysis of Their Optimal Medical Therapy: Insights from the AMERICCAASS RegistryAlex David Sotomayor-Julio, Sebastián Seni-Molina, Juliana María Gutiérrez-Posso, et al.
Nature|January 21, 2026
Publisher Correction: Polyamine-dependent metabolic shielding regulates alternative splicingAmaia Zabala-Letona, Mikel Pujana-Vaquerizo, Belen Martinez-Laosa, et al.
Nature|January 14, 2026
Polyamine-dependent metabolic shielding regulates alternative splicingAmaia Zabala-Letona, Mikel Pujana-Vaquerizo, Belen Martinez-Laosa, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2026
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA RegistryManuel Barreiro-de Acosta, Yamile Zabana, Laura Nieto-García, et al.
Persoonia|October 29, 2020
Fungal Planet description sheets: 1042-1111P W Crous, M J Wingfield, Y-H Chooi, et al.
Pageof 95

Showing results (701-710 of 950) with videos related to

Sort By:
Pageof 95
Scientific Reports|March 11, 2020
NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortiumJose Manuel Sánchez-Maldonado, Manuel Martínez-Bueno, Helena Canhão, et al.
Frontiers in Immunology|November 15, 2021
Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large CohortsJose Manuel Sánchez-Maldonado, Rafael Cáliz, Miguel Ángel López-Nevot, et al.
The Pharmacogenomics Journal|October 6, 2018
Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patientsLuz M Canet, Jose M Sánchez-Maldonado, Rafael Cáliz, et al.
The Pharmacogenomics Journal|February 15, 2019
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patientsLuz M Canet, Jose M Sánchez-Maldonado, Rafael Cáliz, et al.
Acta Otorrinolaringologica Espanola|June 12, 2026
Comprehensive Cancer Centre Accreditation: Experience and Achievements of a Head Neck Cancer UnitF X Avilés-Jurado, I Valduvieco, S Medrano-Martorell, et al.
Global Heart|March 17, 2025
Characterization of 2,500 Patients with Heart Failure and Analysis of Their Optimal Medical Therapy: Insights from the AMERICCAASS RegistryAlex David Sotomayor-Julio, Sebastián Seni-Molina, Juliana María Gutiérrez-Posso, et al.
Nature|January 21, 2026
Publisher Correction: Polyamine-dependent metabolic shielding regulates alternative splicingAmaia Zabala-Letona, Mikel Pujana-Vaquerizo, Belen Martinez-Laosa, et al.
Nature|January 14, 2026
Polyamine-dependent metabolic shielding regulates alternative splicingAmaia Zabala-Letona, Mikel Pujana-Vaquerizo, Belen Martinez-Laosa, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2026
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA RegistryManuel Barreiro-de Acosta, Yamile Zabana, Laura Nieto-García, et al.
Persoonia|October 29, 2020
Fungal Planet description sheets: 1042-1111P W Crous, M J Wingfield, Y-H Chooi, et al.
Pageof 95